Sponsor Pipeline

Joseph C. Wu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT05988463
Dose-Escalation Study of Artesunate Patients With IPF		 date change Primary completion pushed: 2027-11-01 -> 2028-11-01
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05068674 Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left… Chronic Ischemic Left Ventricular Dysfunction Recruiting
NCT06872112 A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary… Pulmonary Arterial Hypertension (PAH) Recruiting
NCT05988463 Dose-Escalation Study of Artesunate Patients With IPF Idiopathic Pulmonary Fibrosis Recruiting
Disease Areas
Idiopathic Pulmonary Fibrosis (1) Hypertension (1)
Get alerts when Joseph C. Wu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free